المؤلفون: Korman T.M.

مصطلحات الفهرس: treatment contraindication, treatment indication, treatment response, azithromycin/ae [Adverse Drug Reaction], azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/dt [Drug Therapy], remdesivir/cb [Drug Combination], remdesivir/dt [Drug Therapy], letter, cardiotoxicity/si [Side Effect], coronavirus disease 2019/dt [Drug Therapy], early intervention, evidence based medicine, health care planning, high risk patient, human, infection control, outpatient care, pneumonia, QT prolongation/si [Side Effect], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27208
American Journal of Epidemiology
Click here for full text options
LibKey Link

المؤلفون: Korman T.M.

مصطلحات الفهرس: treatment contraindication, treatment indication, treatment response, azithromycin/ae [Adverse Drug Reaction], azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/dt [Drug Therapy], remdesivir/cb [Drug Combination], remdesivir/dt [Drug Therapy], letter, cardiotoxicity/si [Side Effect], coronavirus disease 2019/dt [Drug Therapy], early intervention, evidence based medicine, health care planning, high risk patient, human, infection control, outpatient care, pneumonia, QT prolongation/si [Side Effect], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27208
American Journal of Epidemiology
LibKey Link

المؤلفون: Keat K., Ojaimi S., Tran T., West T.A., Malik S., Nalpantidis A., Cannon C., Bhonagiri D., Chan K., Cheong E., Wan Sai Cheong J., Cheung W., Choudhury F., Ernest D., Farah C.S., Fernando S., Kanapathipillai R., Kol M., Murfin B., Naqvi H., Shah A., Wagh A., Frankum B., Riminton S.

مصطلحات الفهرس: single drug dose, staphylococcal bacteremia/dt [Drug Therapy], staphylococcal bacteremia/si [Side Effect], ventilator associated pneumonia/dt [Drug Therapy], ventilator associated pneumonia/si [Side Effect], Victoria, virus pneumonia/dt [Drug Therapy], azithromycin/cb [Drug Combination], azithromycin/pv [Special Situation for Pharmacovigilance], C reactive protein/ec [Endogenous Compound], ceftriaxone/cb [Drug Combination], ceftriaxone/pv [Special Situation for Pharmacovigilance], ferritin/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/dt [Drug Therapy], lopinavir plus ritonavir/ae [Adverse Drug Reaction], lopinavir plus ritonavir/cb [Drug Combination], lopinavir plus ritonavir/dt [Drug Therapy], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], noradrenalin/cb [Drug Combination], piperacillin plus tazobactam/cb [Drug Combination], piperacillin plus tazobactam/dt [Drug Therapy], piperacillin plus tazobactam/iv [Intravenous Drug Administration], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], prednisone/po [Oral Drug Administration], prednisone/pv [Special Situation for Pharmacovigilance], tocilizumab/ae [Adverse Drug Reaction], tocilizumab/cb [Drug Combination], tocilizumab/iv [Intravenous Drug Administration], tocilizumab/pv [Special Situation for Pharmacovigilance], vancomycin/dt [Drug Therapy], vancomycin/iv [Intravenous Drug Administration], fraction of inspired oxygen, tocilizumab/dt [Drug Therapy], acute kidney failure/th [Therapy], adult, aged, article, artificial ventilation, Australian, catheter removal, clinical article, coronavirus disease 2019/dt [Drug Therapy], cytokine release syndrome/dt [Drug Therapy], delirium/si [Side Effect], drug withdrawal, endotracheal intubation, eosinophilia/si [Side Effect], extubation, fatty liver, fever, hepatitis/si [Side Effect], human, hypoxia, intensive care, kidney failure/si [Side Effect], male, middle aged, myositis/si [Side Effect], New South Wales, open study, oxygen saturation, oxygen therapy, priority journal, prone position, QT prolongation/si [Side Effect], respiratory failure/th [Therapy], respiratory tract parameters, retrospective study, sedation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28864
International Journal of Rheumatic Diseases
Click here for full text options
LibKey Link

المؤلفون: Chew C.Y., Saracino A.M., Nikpour M., Mar A.

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link

المؤلفون: Wong A.

مصطلحات الفهرس: bone marrow suppression/si [Side Effect], China, coma/si [Side Effect], convulsion/si [Side Effect], coronavirus disease 2019/dt [Drug Therapy], diarrhea/si [Side Effect], drug efficacy, drug overdose, drug research, evidence based medicine, gastrointestinal symptom/si [Side Effect], headache/si [Side Effect], heart arrhythmia/si [Side Effect], human, hypertransaminasemia/si [Side Effect], hypokalemia/si [Side Effect], hypotension/si [Side Effect], kidney dysfunction/si [Side Effect], liver injury/si [Side Effect], morbidity, mortality, nonhuman, pancreatitis/si [Side Effect], pandemic, patient safety, priority journal, QT prolongation/si [Side Effect], rash/si [Side Effect], self medication, treatment outcome, virus load, virus transmission, activated carbon/dt [Drug Therapy], azithromycin/ae [Adverse Drug Reaction], drug intoxication/dt [Drug Therapy], azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], ceftriaxone/cb [Drug Combination], ceftriaxone/dt [Drug Therapy], ceftriaxone/pv [Special Situation for Pharmacovigilance], chloroquine/ae [Adverse Drug Reaction], chloroquine/cb [Drug Combination], chloroquine/do [Drug Dose], chloroquine/dt [Drug Therapy], article, atrioventricular block/si [Side Effect], bleeding/si [Side Effect], chloroquine/pv [Special Situation for Pharmacovigilance], colchicine/do [Drug Dose], colchicine/dt [Drug Therapy], colchicine/to [Drug Toxicity], colchicine/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/do [Drug Dose], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pv [Special Situation for Pharmacovigilance], ivermectin/do [Drug Dose], ivermectin/dt [Drug Therapy], ivermectin/to [Drug Toxicity], lopinavir plus ritonavir/ae [Adverse Drug Reaction], lopinavir plus ritonavir/do [Drug Dose], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/to [Drug Toxicity], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], remdesivir/ae [Adverse Drug Reaction], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], thalidomide/do [Drug Dose], thalidomide/dt [Drug Therapy], thalidomide/to [Drug Toxicity], thalidomide/pv [Special Situation for Pharmacovigilance], tocilizumab/ae [Adverse Drug Reaction], tocilizumab/dt [Drug Therapy], tocilizumab/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29200
EMA - Emergency Medicine Australasia
Click here for full text options
LibKey Link

المؤلفون: Keat K., Ojaimi S., Tran T., West T.A., Malik S., Nalpantidis A., Cannon C., Bhonagiri D., Chan K., Cheong E., Wan Sai Cheong J., Cheung W., Choudhury F., Ernest D., Farah C.S., Fernando S., Kanapathipillai R., Kol M., Murfin B., Naqvi H., Shah A., Wagh A., Frankum B., Riminton S.

مصطلحات الفهرس: single drug dose, staphylococcal bacteremia/dt [Drug Therapy], staphylococcal bacteremia/si [Side Effect], ventilator associated pneumonia/dt [Drug Therapy], ventilator associated pneumonia/si [Side Effect], Victoria, virus pneumonia/dt [Drug Therapy], azithromycin/cb [Drug Combination], azithromycin/pv [Special Situation for Pharmacovigilance], C reactive protein/ec [Endogenous Compound], ceftriaxone/cb [Drug Combination], ceftriaxone/pv [Special Situation for Pharmacovigilance], ferritin/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/dt [Drug Therapy], lopinavir plus ritonavir/ae [Adverse Drug Reaction], lopinavir plus ritonavir/cb [Drug Combination], lopinavir plus ritonavir/dt [Drug Therapy], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], noradrenalin/cb [Drug Combination], piperacillin plus tazobactam/cb [Drug Combination], piperacillin plus tazobactam/dt [Drug Therapy], piperacillin plus tazobactam/iv [Intravenous Drug Administration], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], prednisone/po [Oral Drug Administration], prednisone/pv [Special Situation for Pharmacovigilance], tocilizumab/ae [Adverse Drug Reaction], tocilizumab/cb [Drug Combination], tocilizumab/iv [Intravenous Drug Administration], tocilizumab/pv [Special Situation for Pharmacovigilance], vancomycin/dt [Drug Therapy], vancomycin/iv [Intravenous Drug Administration], fraction of inspired oxygen, tocilizumab/dt [Drug Therapy], acute kidney failure/th [Therapy], adult, aged, article, artificial ventilation, Australian, catheter removal, clinical article, coronavirus disease 2019/dt [Drug Therapy], cytokine release syndrome/dt [Drug Therapy], delirium/si [Side Effect], drug withdrawal, endotracheal intubation, eosinophilia/si [Side Effect], extubation, fatty liver, fever, hepatitis/si [Side Effect], human, hypoxia, intensive care, kidney failure/si [Side Effect], male, middle aged, myositis/si [Side Effect], New South Wales, open study, oxygen saturation, oxygen therapy, priority journal, prone position, QT prolongation/si [Side Effect], respiratory failure/th [Therapy], respiratory tract parameters, retrospective study, sedation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28864
International Journal of Rheumatic Diseases
LibKey Link

المؤلفون: Chew C.Y., Saracino A.M., Nikpour M., Mar A.

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
LibKey Link

المؤلفون: Wong A.

مصطلحات الفهرس: bone marrow suppression/si [Side Effect], China, coma/si [Side Effect], convulsion/si [Side Effect], coronavirus disease 2019/dt [Drug Therapy], diarrhea/si [Side Effect], drug efficacy, drug overdose, drug research, evidence based medicine, gastrointestinal symptom/si [Side Effect], headache/si [Side Effect], heart arrhythmia/si [Side Effect], human, hypertransaminasemia/si [Side Effect], hypokalemia/si [Side Effect], hypotension/si [Side Effect], kidney dysfunction/si [Side Effect], liver injury/si [Side Effect], morbidity, mortality, nonhuman, pancreatitis/si [Side Effect], pandemic, patient safety, priority journal, QT prolongation/si [Side Effect], rash/si [Side Effect], self medication, treatment outcome, virus load, virus transmission, activated carbon/dt [Drug Therapy], azithromycin/ae [Adverse Drug Reaction], drug intoxication/dt [Drug Therapy], azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], ceftriaxone/cb [Drug Combination], ceftriaxone/dt [Drug Therapy], ceftriaxone/pv [Special Situation for Pharmacovigilance], chloroquine/ae [Adverse Drug Reaction], chloroquine/cb [Drug Combination], chloroquine/do [Drug Dose], chloroquine/dt [Drug Therapy], article, atrioventricular block/si [Side Effect], bleeding/si [Side Effect], chloroquine/pv [Special Situation for Pharmacovigilance], colchicine/do [Drug Dose], colchicine/dt [Drug Therapy], colchicine/to [Drug Toxicity], colchicine/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/do [Drug Dose], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pv [Special Situation for Pharmacovigilance], ivermectin/do [Drug Dose], ivermectin/dt [Drug Therapy], ivermectin/to [Drug Toxicity], lopinavir plus ritonavir/ae [Adverse Drug Reaction], lopinavir plus ritonavir/do [Drug Dose], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/to [Drug Toxicity], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], remdesivir/ae [Adverse Drug Reaction], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], thalidomide/do [Drug Dose], thalidomide/dt [Drug Therapy], thalidomide/to [Drug Toxicity], thalidomide/pv [Special Situation for Pharmacovigilance], tocilizumab/ae [Adverse Drug Reaction], tocilizumab/dt [Drug Therapy], tocilizumab/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29200
EMA - Emergency Medicine Australasia
LibKey Link

المؤلفون: Abd Rahman R., DeKoninck P., Murthi P., Wallace E.M.

مصطلحات الفهرس: preeclampsia/dt [Drug Therapy], priority journal, pruritus/si [Side Effect], review, hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pd [Pharmacology], reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound], toll like receptor 3/ec [Endogenous Compound], toll like receptor 7/ec [Endogenous Compound], toll like receptor 9/ec [Endogenous Compound], vascular protective effect, drug safety, adjuvant therapy, antiinflammatory activity, antioxidant activity, cell protection, drug effect, drug efficacy, drug mechanism, drug targeting, enzyme activity, gastrointestinal symptom/si [Side Effect], headache/si [Side Effect], human, nonhuman, oxidative stress, pathophysiology, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37605
Journal of Maternal-Fetal and Neonatal Medicine
Click here for full text options
LibKey Link

المؤلفون: Abd Rahman R., DeKoninck P., Murthi P., Wallace E.M.

مصطلحات الفهرس: preeclampsia/dt [Drug Therapy], priority journal, pruritus/si [Side Effect], review, hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pd [Pharmacology], reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound], toll like receptor 3/ec [Endogenous Compound], toll like receptor 7/ec [Endogenous Compound], toll like receptor 9/ec [Endogenous Compound], vascular protective effect, drug safety, adjuvant therapy, antiinflammatory activity, antioxidant activity, cell protection, drug effect, drug efficacy, drug mechanism, drug targeting, enzyme activity, gastrointestinal symptom/si [Side Effect], headache/si [Side Effect], human, nonhuman, oxidative stress, pathophysiology, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37605
Journal of Maternal-Fetal and Neonatal Medicine
Click here for full text options
LibKey Link